Novo Nordisk A/S – Total Number of Voting Rights and Share Capital in Novo Nordisk A/S as of 26 April 2024
Yahoo FinanceApr 26 06:16 ET
Novo Nordisk A/S – Reduction of the Share Capital
Yahoo FinanceApr 24 08:48 ET
Weight Loss Drugs and the Many Use Cases in Medical Treatments
Yahoo FinanceApr 19 17:32 ET
Eli Lilly Obesity Therapy Succeeds in Late-stage Trials for Sleep Disorder
Seeking AlphaApr 17 07:04 ET
GLP-1s Benefit Parkinson's: Barclays Sees Implications Across Biopharma
Seeking AlphaApr 12 12:02 ET
No Link Between Weight Loss Drugs and Suicidal Thoughts, EU Regulator Concludes
Seeking AlphaApr 12 07:05 ET
Ginkgo Bioworks Expands R&D Tie-up With Novo Nordisk
Seeking AlphaApr 10 07:34 ET
Weight-loss Drug Shortage Result of 'Unprecedented Demand'
Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own weight-loss treatment Wegovy.
Yahoo FinanceApr 8 17:35 ET
Novo's Ozempic to Face Copycats as Chinese Firm Seeks Approval for Biosimilar
Seeking AlphaApr 3 07:01 ET
CVS, Elevance Health to Cover Novo Nordisk's Wegovy: WSJ
Seeking AlphaMar 28 10:00 ET
Altimmune Falls After Q4 Results; Obesity Drug Data Released
Seeking AlphaMar 27 08:26 ET
Viking Therapeutics Stock Rises on Positive Phase 1 Weight-loss Pill Data
Yahoo FinanceMar 26 12:59 ET
Novo Nordisk Strikes €1bn Deal to Expand Into Heart Disease Treatments
Yahoo FinanceMar 25 11:52 ET
Tesla, Lucid, Novo Nordisk: Trending Tickers
Yahoo FinanceMar 25 10:43 ET
Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease
Yahoo FinanceMar 25 05:59 ET
Wegovy Gains Medicare, Medicaid Coverage for Heart Benefits
Yahoo FinanceMar 22 12:25 ET
Medicare Expands Coverage for Weight Loss Drugs
Seeking AlphaMar 21 13:35 ET
Awiqli (Once-weekly Basal Insulin Icodec) Recommended for Approval for the Treatment of Diabetes by the European Regulatory Authorities
Yahoo FinanceMar 21 11:55 ET
Medicare Coverage for Obesity Drugs Could Strain Federal Budget: CBO
Seeking AlphaMar 20 13:09 ET
NASH Drug Market Expected to Surpass $48B by 2035
Seeking AlphaMar 16 12:57 ET
No Data
No Data